STEEPLES ADRIAN

SEC source: 0001209191-22-020044 · doc4.xml · derivative · entry 2

STEEPLES ADRIAN · CIK 0001580051 · SVP, Managing Director - EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,910

Underlying: Common Stock · 1,910 shares

Expires 2029-03-16

F1 · derivative.exercise_date: This award represents time-based restricted stock and stock options granted to reporting person for the 2022-2024 Performance Period under the Company's 2016 Long-Term Performance Incentive Plan. The restricted stock vests on March 16, 2025 and the stock options are exercisable in three consecutive annual installments: 636 shares on March 16, 2023; 637 shares on March 16, 2024; and 637 shares on March 16, 2025.

SEC source: 0001209191-22-020044 · doc4.xml · nonDerivative · entry 1

STEEPLES ADRIAN · CIK 0001580051 · SVP, Managing Director - EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,552

F1 · shares: This award represents time-based restricted stock and stock options granted to reporting person for the 2022-2024 Performance Period under the Company's 2016 Long-Term Performance Incentive Plan. The restricted stock vests on March 16, 2025 and the stock options are exercisable in three consecutive annual installments: 636 shares on March 16, 2023; 637 shares on March 16, 2024; and 637 shares on March 16, 2025.

SEC source: 0001209191-22-014103 · doc4.xml · nonDerivative · entry 1

STEEPLES ADRIAN · CIK 0001580051 · SVP, Managing Director - EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,964

F1 · shares: Shares surrendered by reporting person to satisfy withholding tax obligation upon vesting of restricted stock granted on August 15, 2019 under the Company's 2016 Long-Term Performance Incentive Plan.

SEC source: 0001209191-21-060462 · doc4.xml · nonDerivative · entry 1

STEEPLES ADRIAN · CIK 0001580051 · SVP, Managing Director - EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,036

F1 · shares: This award represents time-based restricted stock granted to reporting person for the 2021-2023 Performance Period under the Company's 2016 Long-Term Performance Incentive Plan, which vests on March 15, 2024.

SEC source: 0001209191-21-021379 · doc4.xml · derivative · entry 2

STEEPLES ADRIAN · CIK 0001580051 · SVP, Managing Director - EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,319

Underlying: Common Stock · 1,319 shares

Expires 2028-03-15

F1 · derivative.exercise_date: This award represents time-based restricted stock and stock options granted to reporting person for the 2021-2023 Performance Period under the Company's 2016 Long-Term Performance Incentive Plan. The restricted stock vests on March 15, 2024 and the stock options are exercisable in three consecutive annual installments: 439 shares on March 15, 2022; 440 shares on March 15, 2023; and 440 shares on March 15, 2024.

SEC source: 0001209191-21-021379 · doc4.xml · nonDerivative · entry 1

STEEPLES ADRIAN · CIK 0001580051 · SVP, Managing Director - EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,842

F1 · shares: This award represents time-based restricted stock and stock options granted to reporting person for the 2021-2023 Performance Period under the Company's 2016 Long-Term Performance Incentive Plan. The restricted stock vests on March 15, 2024 and the stock options are exercisable in three consecutive annual installments: 439 shares on March 15, 2022; 440 shares on March 15, 2023; and 440 shares on March 15, 2024.

SEC source: 0001209191-20-059097 · doc4.xml · derivative · entry 9

STEEPLES ADRIAN · CIK 0001580051 · SVP, Managing Director - EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 613

Underlying: Common Stock · 1,228 shares

Expires 2025-02-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: The options for this grant vest in three annual installments: 614 shares on February 26, 2019; 614 shares on February 26, 2020; and 613 shares on February 26, 2021.

SEC source: 0001209191-20-059097 · doc4.xml · nonDerivative · entry 8

STEEPLES ADRIAN · CIK 0001580051 · SVP, Managing Director - EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,475

SEC source: 0001209191-20-059097 · doc4.xml · nonDerivative · entry 7

STEEPLES ADRIAN · CIK 0001580051 · SVP, Managing Director - EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,502

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $257.26 to $258.22, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (6) to this Form 4.

SEC source: 0001209191-20-059097 · doc4.xml · nonDerivative · entry 6

STEEPLES ADRIAN · CIK 0001580051 · SVP, Managing Director - EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,870

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $256.20 to $257.14, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (5) to this Form 4.

SEC source: 0001209191-20-059097 · doc4.xml · nonDerivative · entry 5

STEEPLES ADRIAN · CIK 0001580051 · SVP, Managing Director - EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,152

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $255.13 to $255.99, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) to this Form 4.

SEC source: 0001209191-20-059097 · doc4.xml · nonDerivative · entry 4

STEEPLES ADRIAN · CIK 0001580051 · SVP, Managing Director - EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,392

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $253.72 to $254.96, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.

SEC source: 0001209191-20-059097 · doc4.xml · nonDerivative · entry 3

STEEPLES ADRIAN · CIK 0001580051 · SVP, Managing Director - EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,468

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $252.58 to $253.47, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

SEC source: 0001209191-20-059097 · doc4.xml · nonDerivative · entry 2

STEEPLES ADRIAN · CIK 0001580051 · SVP, Managing Director - EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,612

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $251.44 to $252.03, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.

SEC source: 0001209191-20-059097 · doc4.xml · nonDerivative · entry 1

STEEPLES ADRIAN · CIK 0001580051 · SVP, Managing Director - EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,703

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-20-046603 · doc4.xml · derivative · entry 5

STEEPLES ADRIAN · CIK 0001580051 · SVP, Managing Director - EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,188 shares

Expires 2024-02-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The options for this grant vested in three annual installments: 730 shares on February 27, 2018; 729 shares on February 27, 2019; and 729 shares on February 27, 2020.

SEC source: 0001209191-20-046603 · doc4.xml · nonDerivative · entry 4

STEEPLES ADRIAN · CIK 0001580051 · SVP, Managing Director - EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,475

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $202.57 to $202.93, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.

SEC source: 0001209191-20-046603 · doc4.xml · nonDerivative · entry 3

STEEPLES ADRIAN · CIK 0001580051 · SVP, Managing Director - EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,175

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $201.20 to $202.14, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

SEC source: 0001209191-20-046603 · doc4.xml · nonDerivative · entry 2

STEEPLES ADRIAN · CIK 0001580051 · SVP, Managing Director - EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,475

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $200.13 to $200.80, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.

SEC source: 0001209191-20-046603 · doc4.xml · nonDerivative · entry 1

STEEPLES ADRIAN · CIK 0001580051 · SVP, Managing Director - EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,663

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-20-030896 · doc4.xml · derivative · entry 3

STEEPLES ADRIAN · CIK 0001580051 · SVP, Managing Director - EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,213 shares

Expires 2023-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The options for this grant vested in three annual installments: 1,213 shares on February 23, 2017; 1,213 shares on February 23, 2018; and 1,213 shares on February 23, 2019.

SEC source: 0001209191-20-030896 · doc4.xml · nonDerivative · entry 2

STEEPLES ADRIAN · CIK 0001580051 · SVP, Managing Director - EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,475

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $168.63 to $169.335, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.

SEC source: 0001209191-20-030896 · doc4.xml · nonDerivative · entry 1

STEEPLES ADRIAN · CIK 0001580051 · SVP, Managing Director - EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,688

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-20-022168 · doc4.xml · derivative · entry 2

STEEPLES ADRIAN · CIK 0001580051 · SVP, Managing Director - EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,767

Underlying: Common Stock · 2,767 shares

Expires 2027-03-30

F1 · derivative.exercise_date: This award represents time-based restricted stock and stock options granted to reporting person for the 2020-2022 Performance Period under the Company's 2016 Long-Term Performance Incentive Plan. The restricted stock vests on March 30, 2023 and the stock options are exercisable in three consecutive annual installments: 923 shares on March 30, 2021; 922 shares on March 30, 2022; and 922 shares on March 30, 2023.

SEC source: 0001209191-20-022168 · doc4.xml · nonDerivative · entry 1

STEEPLES ADRIAN · CIK 0001580051 · SVP, Managing Director - EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,475

F1 · shares: This award represents time-based restricted stock and stock options granted to reporting person for the 2020-2022 Performance Period under the Company's 2016 Long-Term Performance Incentive Plan. The restricted stock vests on March 30, 2023 and the stock options are exercisable in three consecutive annual installments: 923 shares on March 30, 2021; 922 shares on March 30, 2022; and 922 shares on March 30, 2023.

SEC source: 0001209191-19-046610 · doc4.xml · derivative · entry 3

STEEPLES ADRIAN · CIK 0001580051 · SVP, Managing Director - EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,526

Underlying: Common Stock · 2,526 shares

Expires 2026-02-25

F2 · derivative.exercise_date: This award represents time-based restricted stock and stock options granted to reporting person for the 2019-2021 Performance Period under the Company's 2016 Long-Term Performance Incentive Plan. The restricted stock vests on February 25, 2022 and the stock options are exercisable in three consecutive annual installments: 842 shares on February 25, 2020; 842 shares on February 25, 2021; and 842 shares on February 25, 2022.

SEC source: 0001209191-19-046610 · doc4.xml · nonDerivative · entry 2

STEEPLES ADRIAN · CIK 0001580051 · SVP, Managing Director - EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,841

F2 · shares: This award represents time-based restricted stock and stock options granted to reporting person for the 2019-2021 Performance Period under the Company's 2016 Long-Term Performance Incentive Plan. The restricted stock vests on February 25, 2022 and the stock options are exercisable in three consecutive annual installments: 842 shares on February 25, 2020; 842 shares on February 25, 2021; and 842 shares on February 25, 2022.

SEC source: 0001209191-19-046610 · doc4.xml · nonDerivative · entry 1

STEEPLES ADRIAN · CIK 0001580051 · SVP, Managing Director - EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,325

F1 · shares: This award represents a one-time, time-based restricted stock award granted in recognition of the reporting person's efforts to close the combination between Quaker Chemical Corporation and Houghton International. The restricted stock vests on August 1, 2022.

SEC source: 0001209191-18-018021 · doc4.xml · derivative · entry 7

STEEPLES ADRIAN · CIK 0001580051 · VP & Managing Director - A/P

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,213

Underlying: Common Stock · 1,213 shares

Expires 2023-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The options for this grant vest in three annual installments: 1,213 shares on February 23, 2017; 1,213 shares on February 23, 2018; and 1,213 shares on February 23, 2019.

SEC source: 0001209191-18-018021 · doc4.xml · derivative · entry 6

STEEPLES ADRIAN · CIK 0001580051 · VP & Managing Director - A/P

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 744 shares

Expires 2022-02-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The options for this grant vested in three annual installments: 745 shares on February 25, 2016; 744 shares on February 25, 2017; and 744 shares on February 25, 2018.

SEC source: 0001209191-18-018021 · doc4.xml · nonDerivative · entry 5

STEEPLES ADRIAN · CIK 0001580051 · VP & Managing Director - A/P

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,357

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $150.62 to $151.17, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation ("Quaker"), any security holder of Quaker, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.

SEC source: 0001209191-18-018021 · doc4.xml · nonDerivative · entry 4

STEEPLES ADRIAN · CIK 0001580051 · VP & Managing Director - A/P

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,461

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $149.55 to $149.775, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation ("Quaker"), any security holder of Quaker, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

SEC source: 0001209191-18-018021 · doc4.xml · nonDerivative · entry 3

STEEPLES ADRIAN · CIK 0001580051 · VP & Managing Director - A/P

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,570

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-18-018021 · doc4.xml · nonDerivative · entry 2

STEEPLES ADRIAN · CIK 0001580051 · VP & Managing Director - A/P

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,357

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $149.52 to $150.26, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation ("Quaker"), any security holder of Quaker, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.

SEC source: 0001209191-18-018021 · doc4.xml · nonDerivative · entry 1

STEEPLES ADRIAN · CIK 0001580051 · VP & Managing Director - A/P

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,101

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-18-014025 · doc4.xml · derivative · entry 2

STEEPLES ADRIAN · CIK 0001580051 · VP & Managing Director - A/P

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,841

Underlying: Common Stock · 1,841 shares

Expires 2025-02-26

F1 · derivative.exercise_date: Stock options granted to reporting person under the Company's 2016 Long-Term Performance Incentive Plan and exercisable in three consecutive annual installments: 614 shares on February 26, 2019; 614 shares on February 26, 2020; and 613 shares on February 26, 2021.

SEC source: 0001209191-18-014025 · doc4.xml · nonDerivative · entry 1

STEEPLES ADRIAN · CIK 0001580051 · VP & Managing Director - A/P

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,357

SEC source: 0001209191-17-058876 · doc4.xml · derivative · entry 11

STEEPLES ADRIAN · CIK 0001580051 · VP & Managing Director - A/P

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,426

Underlying: Common Stock · 1,213 shares

Expires 2023-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: The options for this grant vest in three annual installments: 1,213 shares on February 23, 2017; 1,213 shares on February 23, 2018; and 1,213 shares on February 23, 2019.

SEC source: 0001209191-17-058876 · doc4.xml · derivative · entry 10

STEEPLES ADRIAN · CIK 0001580051 · VP & Managing Director - A/P

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 744

Underlying: Common Stock · 1,489 shares

Expires 2022-02-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The options for this grant vest in three annual installments: 745 shares on February 25, 2016; 744 shares on February 25, 2017; and 744 shares on February 25, 2018.

SEC source: 0001209191-17-058876 · doc4.xml · derivative · entry 9

STEEPLES ADRIAN · CIK 0001580051 · VP & Managing Director - A/P

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,209 shares

Expires 2021-02-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The options for this grant vested in three annual installments: 737 shares on February 27, 2015; 736 shares on February 27, 2016; and 736 shares on February 27, 2017.

SEC source: 0001209191-17-058876 · doc4.xml · nonDerivative · entry 8

STEEPLES ADRIAN · CIK 0001580051 · VP & Managing Director - A/P

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,984

SEC source: 0001209191-17-058876 · doc4.xml · nonDerivative · entry 7

STEEPLES ADRIAN · CIK 0001580051 · VP & Managing Director - A/P

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,197

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-17-058876 · doc4.xml · nonDerivative · entry 6

STEEPLES ADRIAN · CIK 0001580051 · VP & Managing Director - A/P

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,984

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $155.38 to $155.77, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation ("Quaker"), any security holder of Quaker, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.

SEC source: 0001209191-17-058876 · doc4.xml · nonDerivative · entry 5

STEEPLES ADRIAN · CIK 0001580051 · VP & Managing Director - A/P

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,198

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.785 to $157.10, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation ("Quaker"), any security holder of Quaker, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

SEC source: 0001209191-17-058876 · doc4.xml · nonDerivative · entry 4

STEEPLES ADRIAN · CIK 0001580051 · VP & Managing Director - A/P

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,473

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-17-058876 · doc4.xml · nonDerivative · entry 3

STEEPLES ADRIAN · CIK 0001580051 · VP & Managing Director - A/P

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,984

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $154.43 to $155.38, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation ("Quaker"), any security holder of Quaker, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.

SEC source: 0001209191-17-058876 · doc4.xml · nonDerivative · entry 2

STEEPLES ADRIAN · CIK 0001580051 · VP & Managing Director - A/P

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,106

SEC source: 0001209191-17-058876 · doc4.xml · nonDerivative · entry 1

STEEPLES ADRIAN · CIK 0001580051 · VP & Managing Director - A/P

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,193

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-17-015964 · doc4.xml · derivative · entry 2

STEEPLES ADRIAN · CIK 0001580051 · VP & Managing Director - A/P

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,188

Underlying: Common Stock · 2,188 shares

Expires 2024-02-27

F1 · derivative.exercise_date: Stock options granted to reporting person under the Company's 2016 Long-Term Performance Incentive Plan and exercisable in three consecutive annual installments: 730 shares on February 27, 2018; 729 shares on February 27, 2019; and 729 shares on February 27, 2020.

SEC source: 0001209191-17-015964 · doc4.xml · nonDerivative · entry 1

STEEPLES ADRIAN · CIK 0001580051 · VP & Managing Director - A/P

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,984